BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26598487)

  • 41. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment.
    Hu G; Chun X; Wang Y; He Q; Gao H
    Oncotarget; 2015 Dec; 6(38):41258-74. PubMed ID: 26517810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Matrix metalloproteinase triggered size-shrinkable gelatin-gold fabricated nanoparticles for tumor microenvironment sensitive penetration and diagnosis of glioma.
    Ruan S; He Q; Gao H
    Nanoscale; 2015 Jun; 7(21):9487-96. PubMed ID: 25909483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spatial controlled multistage nanocarriers through hybridization of dendrimers and gelatin nanoparticles for deep penetration and therapy into tumor tissue.
    Fan Y; Yuan S; Huo M; Chaudhuri AS; Zhao M; Wu Z; Qi X
    Nanomedicine; 2017 May; 13(4):1399-1410. PubMed ID: 28115251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A size switchable nanoplatform for targeting the tumor microenvironment and deep tumor penetration.
    Cun X; Li M; Wang S; Wang Y; Wang J; Lu Z; Yang R; Tang X; Zhang Z; He Q
    Nanoscale; 2018 May; 10(21):9935-9948. PubMed ID: 29770822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Construction and Anti-tumor Effect Evaluation of a Dual-Responsive Hyaluronic Acid Carbon Quantum Dot-Gelatin Nano-Drug Delivery System].
    Li M; Li JP; Wang YS; He Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):577-584. PubMed ID: 34323034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment.
    Hu G; Zhang H; Zhang L; Ruan S; He Q; Gao H
    Int J Pharm; 2015 Dec; 496(2):1057-68. PubMed ID: 26598487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RGD Peptide-Based Target Drug Delivery of Doxorubicin Nanomedicine.
    Sun Y; Kang C; Liu F; Zhou Y; Luo L; Qiao H
    Drug Dev Res; 2017 Sep; 78(6):283-291. PubMed ID: 28815721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The development of novel tumor targeting delivery strategy].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
    Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
    J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multistage Nanoparticle Delivery System-A New Approach to Cancer Therapeutics.
    Li G; Chen L; Xin P; Huang J; Wu J
    J Biomed Nanotechnol; 2020 Nov; 16(11):1570-1587. PubMed ID: 33461650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.
    Chen B; Dai W; He B; Zhang H; Wang X; Wang Y; Zhang Q
    Theranostics; 2017; 7(3):538-558. PubMed ID: 28255348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deep penetration of nanoparticulate drug delivery systems into tumors: challenges and solutions.
    Li L; Sun J; He Z
    Curr Med Chem; 2013; 20(23):2881-91. PubMed ID: 23651305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploring the tumor microenvironment with nanoparticles.
    Miao L; Huang L
    Cancer Treat Res; 2015; 166():193-226. PubMed ID: 25895870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mini-Review: Opportunities and challenges in the techniques used for preparation of gelatin nanoparticles.
    Khan SA
    Pak J Pharm Sci; 2020 Jan; 33(1):221-228. PubMed ID: 32122852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor microenvironment-responsive size-switchable drug delivery nanosystems.
    Hu Y; Gao S; Khan AR; Yang X; Ji J; Xi Y; Zhai G
    Expert Opin Drug Deliv; 2022 Mar; 19(3):221-234. PubMed ID: 35164610
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.